Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Biorxiv : the Preprint Server for Biology|July 10, 2023
Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing is associated with therapeutic response to splicing inhibitorCarolyn Jablonowski, Waise Quarni, Shivendra Singh, et al.
Nature Communications|November 13, 2023
A CRISPR-drug perturbational map for identifying compounds to combine with commonly used chemotherapeuticsHyeong-Min Lee, William C Wright, Min Pan, et al.
Nature Communications|April 22, 2020
Super-resolution imaging reveals the evolution of higher-order chromatin folding in early carcinogenesisJianquan Xu, Hongqiang Ma, Hongbin Ma, et al.
Elife|March 15, 2024
Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitorCarolyn M Jablonowski, Waise Quarni, Shivendra Singh, et al.
Journal of Medicinal Chemistry|February 3, 2006
PABA/NO as an anticancer lead: analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activityJoseph E Saavedra, Aloka Srinivasan, Gregory S Buzard, et al.
Kidney International Reports|August 25, 2020
The Adverse Effect of COVID Pandemic on the Care of Patients With Kidney Diseases in IndiaNarayan Prasad, Mansi Bhatt, Sanjay K Agarwal, et al.
Science Advances|November 17, 2021
Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma modelsShivendra Singh, Waise Quarni, Maria Goralski, et al.
Nature Communications|May 8, 2026
CRISPR base editor screening identifies spectrum of MEN1 mutations impacting menin inhibitors in clinical trialsWallace Bourgeois, Hannah E Rice, Daniela V Wenge, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
RBM39 degrader invigorates natural killer cells to eradicate neuroblastoma despite cancer cell plasticityShivendra Singh, Jie Fang, Hongjian Jin, et al.
Cell Reports. Medicine|March 20, 2024
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastomaAhmed Abu-Zaid, Jie Fang, Hongjian Jin, et al.
Pageof 13